NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Clinical trial condition
Immunoblastic Lymphadenopathy
Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.
192 public trials
11 recruiting studies
Immunoblastic Lymphadenopathy trial results
NCT02232516
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
- Locations
-
- City of Hope Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Northwestern University Chicago, Illinois, United States
- Weill Cornell Medicine New York, United States
NCT03593018
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +6 more
- Locations
-
- University Hospital for Internal Medicine - University Hospital Graz Graz, Austria
- Medical University of Vienna Vienna, Austria
- A. Z. Sint-Jan Brugge-Oostende AV Bruges, Belgium
- Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium
NCT02588651
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Angioimmunoblastic T-cell Lymphoma, Enteropathy Associated T-cell Lymphoma, +22 more
- Locations
-
- Wayne State University, Karmanos Cancer Institute Detroit, Michigan, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT05290155
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hematologic Diseases, +21 more
- Locations
-
- Xianmin General Song Shanghai, China
Completed
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
- Locations
-
- British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT02168140
- Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT00577798
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiac Toxicity, +55 more
- Locations
-
- University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States
NCT01336933
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Mayo Clinic, Arizona Scottsdale, Arizona, United States
- Stanford University Stanford, California, United States
- Emory University School Of Medicine Atlanta, Georgia, United States
- University of Chicago Chicago, Illinois, United States